• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Amgen Charts Indicate Bounce Possible Within a Longer-Term Downtrend

In the short run the stock of this biotech giant could bounce as momentum has slowed, but the bigger picture is for further weakness.
By BRUCE KAMICH
Jun 03, 2019 | 09:01 AM EDT
Stocks quotes in this article: AMGN

At the top of Jim Cramer's "Mad Money" program on CNBC last Friday, Jim offered a cautious game plan for this week's action. The week begins with an analyst meeting with Amgen Inc. (AMGN) . Cramer said this biotech giant needs to turn things around. The charts of Amgen, which is a holding of Cramer's Action Alerts PLUS charitable trust, reflect that dour opinion; let's check them out.

In this daily bar chart of AMGN, below, we can see that prices peaked back in September. A downtrend has been in place since, with new lows made this past month. A series of lower lows and lower highs are the simple definition of a downtrend.

We also can use math to tell us the trend, and AMGN is trading below both the declining 50-day moving average line and the slower-to-react 200-day line. The volume pattern is hard to interpret, but the daily On-Balance-Volume (OBV) line has been in a downtrend from December.

In the lower panel of this first chart is the 12-day price momentum study or indicator. This leading indicator shows a higher low from April to May while prices make a lower low. This difference is what technical analysts call a bullish divergence -- price is doing one thing and the indicator is doing something else. A bullish divergence can foreshadow a bounce or rally. This is not a big divergence, but it is a start.

In this weekly bar chart of AMGN, below, we can see the price action of the past three years. Prices were in an uptrend from late 2016 to late 2018, but a downtrend is now in place with prices below the declining 40-week moving average line. The weekly OBV line is pointed down, which tells us that sellers of AMGN have been more aggressive this year. The weekly Moving Average Convergence Divergence (MACD) oscillator is below the zero line in a sell configuration.

In this Point and Figure chart of AMGN, below, we can see a large distribution (sell) pattern with a potential downside price target or objective of $152.

Bottom line strategy: AMGN is in a downtrend and probably pointed lower. In the short run this stock could bounce as momentum has slowed, but the bigger picture is for further weakness to the $152 area.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.


Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Biotechnology | Pharmaceuticals | Mad Money | Real Money

More from Stocks

Traders Appear Stuck as Tariff Deadline Looms

James "Rev Shark" DePorre
Dec 9, 2019 4:32 PM EST

Many traders have a theory about what might come of the China trade talks with Washington, but any bet is a gamble.

Taking a Hit From Pot Stocks? Harvest Tax Losses Into an ETF

Debra Borchardt
Dec 9, 2019 2:30 PM EST

As the year winds down, many frothed up stocks of cannabis companies dipped -- here's a way to roll up your investments going into the new year.

Enphase Energy Is My 'Stock of the Week'

James "Rev Shark" DePorre
Dec 9, 2019 1:58 PM EST

ENPH has had huge, quick growth.

I See a Good Trade in Store for Macy's

Timothy Collins
Dec 9, 2019 1:31 PM EST

Sure, many other big box retailers and niche retail names look better for investing, but M offers some fantastic volatility for a play.

Jim Cramer: Markets, What Happened This Year, and the 1-2 Punch That Concerns Me

Jim Cramer
Dec 9, 2019 1:00 PM EST

Let me take a stab at what's going on here.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:02 AM EST BOB LANG

    Added Some Peleton

    This stock is starting to gain some traction, the ...
  • 01:06 PM EST CAROLYN BORODEN

    MRK and LVS Targets Coming Up

    View Chart » View in New Window »  LVS View C...
  • 12:01 PM EST BOB LANG

    Rolling Up Apple

    Just the other day we added some Apple calls on th...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login